A Review Of 85 cash
5 million1. The remaining Jounce workers will do the job to complete the sale of the corporate, perform actions To maximise the value with the CVR, operate in order that individuals to the Find and INNATE trials have the chance to continue receiving therapy with vopratelimab, JTX-8064 and pimivalimab and to or else ensure a clean transition to Conc